About Wei Li
Form D filings for Cytovia from 2022 to 2023 list Wei Li as chief scientific officer.
Wei Li first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Wei Li in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wei Li works with at each company, as listed on that company's latest Form D.
Cytovia, Inc. · Form D, Jan 26, 2023
DT
Daniel Teper
Chief Executive Officer & Director
AR
Armin Rath
Head of New Product Development
MN
Michael Noonan
Chief Financial Officer
GF
Gregory Fiore
Director
GS
Gilles Seydoux
Director